92 related articles for article (PubMed ID: 9173693)
1. [Long-term follow-up of HBeAg-positive patients after interferon-alpha treatment for chronic hepatitis B].
Goeser T
Z Gastroenterol; 1997 Mar; 35(3):233-5. PubMed ID: 9173693
[No Abstract] [Full Text] [Related]
2. Long-term follow-up of patients with chronic hepatitis B after interferon treatment.
Teuber G; Dienes HP; Meyer Zum Büschenfelde KH; Gerken G
Z Gastroenterol; 1996 Apr; 34(4):230-6. PubMed ID: 8686350
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
[TBL] [Abstract][Full Text] [Related]
5. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
[TBL] [Abstract][Full Text] [Related]
6. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
[TBL] [Abstract][Full Text] [Related]
7. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
[TBL] [Abstract][Full Text] [Related]
8. [Interferon treatment in chronic hepatitis B].
Pastore G; Santantonio T; Milella M; Iacovazzi T; Longo A; Pietromatera G
Minerva Gastroenterol Dietol; 1995 Mar; 41(1):97-102. PubMed ID: 7619970
[No Abstract] [Full Text] [Related]
9. Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B.
Kanai K; Kako M; Aikawa T; Hino K; Tsubouchi H; Takehira Y; Iwabuchi S; Kawasaki T; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
Am J Gastroenterol; 1996 Oct; 91(10):2150-6. PubMed ID: 8855739
[TBL] [Abstract][Full Text] [Related]
10. Chronic viral hepatitis--benefits of current therapies.
Hoofnagle JH; Lau D
N Engl J Med; 1996 May; 334(22):1470-1. PubMed ID: 8618588
[No Abstract] [Full Text] [Related]
11. [Long term study of the treatment with recombinant alfa 2b interferon in chronic active hepatitis due to B virus in children and adolescents].
Castañeda Guillot C; Escobar Capote MD; García Bacallao E; Borbolla Bousquets E
G E N; 1994; 48(4):219-25. PubMed ID: 7557276
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of chronic hepatitis B with interferon alpha-2b].
Baumgarten R; Müller R; Markus R; Hintsche-Kilger B; Fengler JD; Meisel H
Gastroenterol J; 1990; 50(3):124-8. PubMed ID: 2288653
[TBL] [Abstract][Full Text] [Related]
13. [Re-treatment with interferon-alpha in chronic hepatitis B and C virus infection].
Teuber G; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
Z Gastroenterol; 1995 Feb; 33(2):94-8. PubMed ID: 7725763
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
15. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
Janssen HL; Berk L; de Man RA; Heijtink RA; Schalm SW
Ned Tijdschr Geneeskd; 1992 Apr; 136(17):835-9. PubMed ID: 1522928
[TBL] [Abstract][Full Text] [Related]
16. [Selection of patients with chronic hepatitis B for therapy with alpha-interferon].
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Z Arztl Fortbild (Jena); 1993 Apr; 87(4):273-8. PubMed ID: 8511938
[No Abstract] [Full Text] [Related]
17. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
[TBL] [Abstract][Full Text] [Related]
18. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of interferon alpha alone or after prednisone withdrawal in chronic hepatitis B. Interim report and review of the literature.
Gonzalez-Mateos F; Garcia-Monzon C; Garcia-Buey L; Garcia-Sanchez A; Pajares JM; Moreno-Otero R
Hepatogastroenterology; 1995; 42(6):893-9. PubMed ID: 8847042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
